Advanced Filters
noise
Found 840 clinical trials
M Mark I Boulos, MD, MSc

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing

Obstructive sleep apnea (OSA), which causes abnormal pauses in breathing during sleep, is common in patients with vascular cognitive impairment (VCI) and Alzheimer's disease (AD), and exacerbates the cognitive deficits seen in these conditions. OSA is typically treated with continuous positive airway pressure (CPAP), which has been shown to improve …

years of age All Phase N/A
K Kathy Xie, PhD

Mindfulness for Cognition in Early-stage Alzheimer's Disease

The goal of this clinical trial is to learn if mindfulness meditation can improve outcomes in older adults with and without cognitive impairment. The main questions it aims to answer are: How does mindfulness impact thinking and memory? How does mindfulness influence brain function and structure? How does mindfulness affect …

50 - 100 years of age All Phase N/A
M Mariah N Brown, MPH

CBD for Individuals at Risk for Alzheimer's Disease

This is a double-blind, randomized controlled trial designed to test the effects of cannabidiol (CBD) on validated biomarkers of Alzheimer's disease (AD) progression, and behavioral, neurocognitive, and clinical measures, with putative mechanisms of action.

55 - 85 years of age All Phase 2
M Mariana Figueiro, PhD

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

Participants will randomly be placed into one of four groups and experience one of the four following conditions: (1) a placebo light that provides a 40 hertz (Hz) flicker (rhythmic light [RL]); (2) a placebo light with a random flicker (placebo condition for rhythmic light); (3) a light source that …

55 years of age All Phase N/A
C Christian Esspino

Palliative Care for Patients With Dementia

A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to …

65 years of age All Phase N/A
F Frank Puga, PhD

Coaching Dementia Caregivers to Master Care-Resistant Behavior

266 family caregivers will be randomly assigned to either immediate intervention or delayed intervention groups. All caregivers will complete baseline surveys and 3 weeks of daily diaries. The immediate intervention group will receive 12 weeks of CuRB-IT. They will complete 3 rounds of 3-week daily diaries followed by an intermittent …

18 - 95 years of age All Phase N/A
H Hsien-Yuan Lane, M.D., Ph.D

Efficacy Biomarkers of DAOIB for Dementia

This open-label clinical trial will enroll patients with aMCI or mild AD, and they will be treated with DAOIB for 24 weeks. We will assess the patients before entering the study, 8 weeks, 16 weeks, and end point (24 weeks) of the study, and measure blood NMDA and oxidative stress …

50 - 90 years of age All Phase 2
J Johan Abrahams

Adherence by Music to Exercise in Dementia: Group Therapy

The aim of this study is to asses the effect of a music and video-based group exercise therapy on motivation, physical functioning, cognition and well-being in older adults with moderate dementia.

65 years of age All Phase N/A
Y Yi-Chun Kuan

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention

A 3-arm randomized controlled trial of multi-modal non-pharmacological Intervention for preventing the risk of dementia in Taiwanese geriatric people

60 - 90 years of age All Phase N/A
S Sophie LENGAGNE

Dance Workshop for Institutionalized Seniors With Behavioral and Psychological Symptoms of Dementia

It is estimated that the prevalence of dementia in France is 5% for people over 65 years of age and that this increases to 18% for people over 75 years of age. Behavioral disorders are frequent in patients with dementia and are the main cause of institutionalization, representing up to …

65 years of age All Phase N/A

Simplify language using AI